please find enclosed announcement
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech has received a Good Laboratory Practice (GLP) compliance certificate from India's National GLP Compliance Monitoring Authority (NGCMA) under the Department of Science & Technology. The certification adds three new high-value study areas: toxicity studies in dogs (including repeated dose evaluations), carcinogenicity studies for long-term safety assessment, and in vitro eye irritation/serious eye damage studies. These additions strengthen the company's ability to conduct globally acceptable non-clinical safety studies and support international regulatory filings for product registration. The company already held GLP accreditation in other areas and is now expanding its scope of services.
This regulatory accreditation expands Vivo Bio Tech's service portfolio and enhances its credibility as a comprehensive GLP-compliant research testing facility, potentially opening up new business opportunities in international pharma and biotech contracts. For shareholders, this is a positive capability-enhancing milestone, though its near-term financial impact will depend on the company's ability to convert this expanded accreditation into new client wins.